Evidence map›Paper›PMID 32340490›Full record

ArticleEuropean journal of ophthalmology2020

Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management.

Xiaowan Ma, Ke Ning, Sayena Jabbehdari, Philipp P Prosseda, Yang Hu, Ann Shue, Scott R Lambert, Yang Sun

Abstract read
In one paragraph

Article in European journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Primary Cilia of Astrocytes in the Retina in Development and Disease.Investigative ophthalmology & visual science · 2026
    Article
  4. Article
  5. Strabismus in Genetic Syndromes: A Review.Clinical & experimental ophthalmology · 2025
    Review
  6. Article
  7. Article
  8. Clinical variation in Lowe syndrome: what and how?Frontiers in cell and developmental biology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Management of cataract surgery in Lowe syndrome.International journal of ophthalmology · 2022
    Article
  19. Primary Cilia in Amacrine Cells in Retinal Development.Investigative ophthalmology & visual science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaowan MaXiamen Changgung Hospital, Xiamen, China.
Ke NingDepartment of Ophthalmology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Sayena JabbehdariDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA.ORCID https://orcid.org/0000-0001-8850-4956
Philipp P ProssedaDepartment of Ophthalmology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Yang HuDepartment of Ophthalmology, School of Medicine, Stanford University, Palo Alto, CA, USA.ORCID https://orcid.org/0000-0002-7980-1649
Ann ShueDepartment of Ophthalmology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Scott R LambertDepartment of Ophthalmology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Yang SunDepartment of Ophthalmology, School of Medicine, Stanford University, Palo Alto, CA, USA.ORCID https://orcid.org/0000-0001-6133-3392

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Alfredo Dubra · 2017 to 2026
$8.0M
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve RegenerationR01EY024932 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI Yang Hu · 2015 to 2026
$4.8M
Neuroprotection by Modulating ER Stress in GlaucomaR01EY023295 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI HU, YANG · 2013 to 2022
$3.8M
The role of primary cilia in glaucoma pathogenesisR01EY025295 · NEI · STANFORD UNIVERSITY · PI Yang Sun · 2016 to 2026
$3.5M
Developing Novel Neuroprotective Strategies for EAE/Optic NeuritisR01EY028106 · NEI · STANFORD UNIVERSITY · PI HU, YANG · 2018 to 2021
$1.9M
Phosphoinositide signaling in glaucoma: rescue strategies for Lowe syndromeR01EY032159 · NEI · STANFORD UNIVERSITY · PI SUN, YANG · 2021 to 2024
$1.6M
Glaucoma Pathogenesis of Oculocerebrorenal syndrome of LoweK08EY022058 · NEI · STANFORD UNIVERSITY · PI SUN, YANG · 2012 to 2016
$994k
Development and Characterization of Silicone Oil-Induced Reversible Ocular Hypertension Glaucoma Model R21EY031063 · NEI · STANFORD UNIVERSITY · PI HU, YANG · 2019 to 2019
$324k
Shedding light on glaucoma: optogenetics regulation of ciliary phosphoinositidesI01CX001481 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI SUN, YANG · 2017 to 2025
–
CSRD VA I01 CX001481NEI NIH HHS K08 EY022058NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY023295NEI NIH HHS R01 EY024932NEI NIH HHS R01 EY025295NEI NIH HHS R01 EY028106NEI NIH HHS R01 EY032159NEI NIH HHS R21 EY031063
6 · The paper itself

Abstract

backgroundLowe syndrome is a rare X-linked disease that is characterized by renal dysfunction, developmental delays, congenital cataracts and glaucoma. Mutations in the oculocerebral renal syndrome of Lowe ( MATERIALS AND

methodsA retrospective review was conducted on the prevalence and characteristics of ocular findings among families of patients with Lowe syndrome with 137 uniquely affected individuals.

resultsOf 137 patients, all had bilateral congenital cataracts. Nystagmus was reported in 69.3% of cases, glaucoma in 54.7%, strabismus in 35.0%, and corneal scar in 18.2% of patients. Glaucoma was reported as the most common cause of blindness (46%) followed by corneal scars (41%). Glaucoma occurred in 54.7% of patients and affected both eyes in the majority of cases. Of these patients, 55% underwent surgery for glaucoma, while the remaining patients used medications to control their eye pressure. Timolol and latanoprost were the most commonly used medications. Although trabeculectomy and goniotomy are commonly used for pressure management, aqueous tube shunts had the best outcomes.

conclusionOcular manifestations in individuals with Lowe syndrome and carriers with

Indexed as

CataractCataract ExtractionChildChild, PreschoolCorneal DiseasesEye DiseasesFemaleGlaucomaHumansInfantInfant, NewbornMaleNystagmus, PathologicOculocerebrorenal SyndromePhosphoric Monoester HydrolasesPrevalenceOCRL protein, humanPhosphoric Monoester Hydrolasescongenital cataractcongenital glaucomaFanconi syndromeLowe syndromeOCRL gene

Identifiers

PMID32340490
PMCPMC8177091

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.